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Within sub-Saharan Africa, HIV infection has become a common 
comorbidity among children with severe acute malnutrition (SAM) and 
some evidence of its effect on survival of children with SAM has begun 
to emerge.[1-3] Some observational studies conducted in Africa have 
shown that children with SAM who are HIV-positive are more at risk 
of dying compared with their HIV-negative counterparts,[4-6] especially 
if they are marasmic.[3,7] In some cases of SAM, HIV is comorbid with 
other conditions such as lower respiratory tract infections (LRTIs) and 
tuberculosis.[8] According to Heikens,[9] these comorbidities have led to 
an epidemic of secondary SAM, which is more frequently associated with 
poor outcomes than primary SAM due to food shortage and non-HIV/
TB-related infections. 
However, the evidence of the effect of HIV infection and other baseline 
comorbidities on nutritional recovery among children with SAM who 
are <5 years of age, remains sparse and inconclusive. The differential 
effect of the World Health Organization (WHO) clinical stages of 
HIV on nutrition recovery has not been sufficiently, if at all, explored; 
inconsistent findings have been reported in a limited number of studies. 
For example, some studies in resource-poor sub-Saharan countries have 
shown that although HIV-positive, severely malnourished children can 
achieve normal nutritional status when treated according to specific 
treatment guidelines, the recovery is slower when compared with HIV-
negative children.[2,5,10] Fergusson and colleagues, on the other hand, have 
reported similar nutritional recovery (mean 8.9 v. 8.0 g/kg/day) among 
HIV-positive and HIV-negative severely malnourished children who 
survived.[11] 
Further to this, the relationship between the rate of weight gain (RWG) 
and duration of refeeding and treatment (DRT), comparing HIV-positive 
and -negative SAM patients, remains unclear. Initial observations from 
two hospitals in which this study was conducted revealed that in some 
instances children were being discharged without due regard to whether 
they had gained weight sufficiently during the rehabilitation phase. This 
was partly because the healthcare workers were not sure as to how long the 
child needed to be in care to achieve optimal weight gain. An enquiry into 
this aspect of care was important, particularly because of the insufficient 
resources available to provide prolonged care in the study setting. There 
was also some speculation among healthcare workers that HIV-positive 
children would not gain weight at the same rate as their HIV-negative 
counterparts, no matter how well and for how long the WHO 10-step 
guidelines were used to treat them. This anecdote is partly supported by 
the recent WHO update on the WHO 10-step guidelines for management 
of SAM[12] which highlighted the existing gap in knowledge regarding 
nutritional recovery among children with SAM who are HIV-positive and 
are treated according to the current WHO treatment modality. 
This study sought to assess whether there was a relationship between 
the RWG and the DRT in a sample of children with SAM who survived, 
and were discharged, following treatment using the WHO 10-step 
treatment guidelines for management of severe malnutrition. The study 
also assessed whether this relationship was affected by baseline clinical 
characteristics, specifically investigating HIV co-infection, HIV disease 
stage, and SAM syndromic manifestation. Lastly, the study looked at 
HIV-negative SAM patients as well as HIV-positive SAM patients, at 
different HIV disease stages, to estimate how long it took for them to 
achieve a certain number of units of the RWG. 
As the nature of this study was operational, assessing these relationships 
was important not only to promote practices that would ultimately lead 
Background. Evidence of the effects of HIV infection and clinical stage on the duration of refeeding and treatment (DRT) and the rate of weight 
gain (RWG) in severely malnourished children remains inconclusive.
Objectives. To determine whether the RWG and DRT differ by baseline clinical characteristics, and to assess the effect of HIV status and disease 
stage on the relationship between these two clinical outcomes. 
Methods. This was a retrospective record review of 346 patiens discharged between 2009 and 2013 following treatment for severe acute 
malnutrition (SAM) at two rural hospitals in South Africa. 
Results. A third of the sample was HIV-positive, the RWG (measured as g/kg/day) was significantly slower in HIV-positive patients compared 
with HIV-negative cases (mean 5.2, 95% confidence interval (CI) 4.47 - 5.93 v. mean 8.51; CI 7.98 - 9.05; p<0.0001) and cases at stage IV of HIV 
infection had a significantly slower RWG (mean 3.97; CI 2.33 - 5.61) compared with those at stages I (mean 7.64; CI 6.21 - 9.07) (p<0.0001) and 
II (mean 5.87; CI 4.74 - 6.99). The mean DRT was longer in HIV-positive cases and those at advanced stages of HIV infection. HIV-positive cases 
were renourished and treated for almost 3.5 times longer than their HIV-negative counterparts to achieve a moderate RWG (5 - 10 g/kg/day).
Conclusion. This study highlights the need to reconsider energy requirements for HIV-positive cases at different clinical stages, for more rapid 
nutritional recovery in under-resourced settings where prolonged hospitalisation may be a challenge. 
S Afr J Child Health 2017;11(2):86-92. DOI:10.7196/SAJCH.2017.v11i2.1194
The impact of HIV infection and disease stage on 
the rate of weight gain and duration of refeeding 
and treatment in severely malnourished children in 
rural South African hospitals
M Muzigaba,1,2 PhD, MPH, MPhil, BSc; B Sartorius,3 PhD, EPIET, MSc, BSc (Hons), BSc;  
T Puoane,2 Dr PH, MPH, BCur, BA SocSci; B van Wyk,2 DPhil, MSc, BSc; D Sanders,2 MB ChB, DCH, MRCP, DTPH, DSc
1 School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa 
2 Faculty of Community and Health Sciences, School of Public Health, University of the Western Cape, Bellville, South Africa 
3 Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa 
Corresponding author: M Muzigaba (mochemoseo@gmail.com)
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
RESEARCH
87        SAJCH     JUNE 2017    Vol. 11    No. 2
to better nutritional recovery at ward level, but also to enable the hospital 
administrators and the clinical teams to make informed decisions 




This study was approved by the University of the Western Cape 
Research Ethics Committee (ref. no. 12/10/37). The study consisted of a 
retrospective review of medical treatment records of children admitted 
with SAM in the study setting who survived and were discharged 
following treatment.
Setting
This study was conducted in two rural district hospitals in the Eastern 
Cape Province (EC), South Africa (SA). The hospitals were located in the 
former Transkei, an apartheid-era homeland and one of the most under-
resourced regions in SA.[13] These hospitals were selected based on the 
fact that they had participated in the initial province-wide intervention to 
improve the management of SAM in the EC. They were also found to have 
implemented the WHO 10-step guidelines more effectively than other 
hospitals in the region.[13] Throughout the study period - January 2009 
to May 2013 - monthly SAM admissions in both hospitals constituted an 
average of 50% of the total paediatric ward admissions. The hospitals also 
served a catchment area with high HIV prevalence, with a monthly average 
HIV co-infection rate of 45% among children admitted with SAM. 
Participants 
Eligibility and selection 
The unit of analysis in this study was the patient’s medical treatment 
record. The treatment records were purposefully selected by one 
researcher (MM) during regular visits to each hospital, based on a set 
of eligibility criteria. In total, 346 medical records were reviewed over 
the study period. The research team reviewed updated medical records 
at 3-month intervals during hospital visits. Medical records were eligible 
for review if they belonged to children aged between 6 and 60 months, 
who were admitted at any of the two hospitals with SAM between 
January 2009 and May 2013, and were discharged following treatment. 
Children were discharged if they: (i) completed the transition to catch 
up and were eating well; (ii) they had no oedema; (iii) had completed 
antibiotic treatment; (iv) had received electrolytes and micronutrients 
for at least 2 weeks; (v) their immunisation was up-to-date; and 
(vi) their road-to-health card had been updated. The exclusion of 
patients that died was logical, as most of these patients died during the 
first three days of admission or earlier before the stabilisation phase. 
Thus, their RWG could not be determined. Other inclusion criteria 
included having patient treatment records with clearly defined SAM 
syndromic classifications based on the Wellcome classification system,[14] 
having records showing HIV test results and HIV clinical stage for HIV-
positive patients, and having had a complete treatment record while in 
the hospital. A comprehensive written medical examination by a doctor, 
and the discharge criteria followed for patients who did not die while on 
treatment, were also used as eligibility criteria. 
Patient management and follow-up
Treatment records were accumulated over the study period following 
standardised treatment of patients admitted with SAM. A patient with 
SAM brought to the hospital was seen by a doctor in the outpatient 
department, where the admitting doctor provided the diagnosis and the 
course of treatment to be followed based on the WHO 10-step guidelines. 
This information was recorded in standardised patient treatment charts 
as the basis for follow-up treatment and for record-keeping. For patients 
that were admitted to the ward, their caregivers were requested to 
provide consent for their children to take part in the study and also 
so that they would both be screened for HIV infection. Children who 
tested HIV-positive were identified and their treatment charts set aside 
for HIV disease staging by the doctor during follow-up ward rounds. 
Based on the screening results, two broad groups were formed: group 
A (HIV-negative patients) and group B (HIV-positive patients). Group 
B was further divided into four categories based on the clinical stage of 
HIV infection as defined by the WHO guidelines for staging infants and 
children.[15] The recruitment process is summarised in Fig. 1.
All SAM patients were treated at the hospital using the recommended 
WHO 10-steps guidelines for management of SAM.[16] Children with 
SAM and HIV co-infection were referred to an HIV clinic situated within 
the hospital premises for initial or follow-up treatment. 
Variable definition and measurement
The outcome variables in this study were DRT and RWG. DRT was 
defined as the total number of days - from admission to discharge 
- during which a SAM patient was treated for SAM and other 
comorbidities as per the WHO treatment guidelines. This was computed 
from the admission and discharge dates in the patient treatment chart. 
The RWG was defined as the number of grams gained per kilogram of 
body weight per day (g/kg/day) during the rehabilitation phase. Patients 
with the RWG ≤0 g/kg/day were considered as those who lost or did 
not gain weight; whereas those with ≤5 g/kg/day had poor weight gain; 
5 - 10 g/kg/day had moderate weight gain; and >10 g/kg/day had good 
weight gain. The data used to compute this measure were obtained from 
a standardised patient weight monitoring chart which was included in 
Two hospitals (A and B) selected on account of having been the 
best in the region to optimally implement the WHO guidelines 
for some time
Admission of SAM cases at 
hospital A – paediatric ward
HIV screening for all SAM cases (plus caregiver) in each hospital 
following consent by a parent or guardian
Admission of SAM cases at 





Stage I, II, III, IV
Treatment of all SAM cases using the recommended 
WHO guidelines
Retrospective patient record review to document baseline 
clinical characteristics and treatment outcomes
Group A (eligible)
(HIV-negative SAM cases; 
n=258)
Group B (eligible)
(HIV-positive SAM cases; 
n=196)
Group X (eligible)
(Group A who survived; 
n=229)
Group Y (eligible)




Fig. 1. Flow chart of the participant recruitment and data extraction process.
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the patient treatment record. The weight-for-height z-scores were not 
considered as a measure of nutritional recovery as the height data were 
not always recorded in the patient treatment record. 
Predictor variables and possible confounders included baseline clinical 
characteristics, such as SAM classification, oedema grade, dermatosis 
grade, presence of LRTIs, critical illness on admission, presence of other 
comorbidities, HIV status, and the WHO HIV/AIDS disease stage. 
Classification of SAM followed the Wellcome system,[14] primarily because 
there was evidence of inconsistent measurement of patients’ height/
length. HIV testing was done using the HIV polymerase chain reaction 
(PCR) test, following confidential and private counselling of the caregiver 
by a professionally trained nurse. HIV clinical staging was done by the 
admitting doctor as per the WHO guidelines.[15] Oedema and dermatosis 
were graded on admission as none, mild (+), moderate (++), and severe 
(+++).[17,18] The LRTIs was an umbrella term used for patients with 
comorbidities such as pneumonia, bronchitis and other infections below 
the larynx. Tuberculosis was not a common comorbidity in the treatment 
records, which may be a result of under-diagnosis or misdiagnosis of the 
condition in the study setting. Critical illness and other comorbidities 
were defined based on clinical diagnostic information in the patients’ 
medical records. Definition of cases as ‘critically ill’ was based on whether 
or not they were admitted with one or a combination of five clinical 
features, namely: (i) depressed conscious state (prostration or coma); 
(ii) bradycardia; (iii) evidence of shock with or without dehydration; 
(iv) hypoglycaemia and/ or (v) hypothermia, as defined by Maitland et al.[19] 
Other comorbidities, directly or indirectly related to SAM, were also noted, 
for example: lethargy, hyponatraemia and hypokalaemia, dehydration, 
deep acidotic breathing, anaemia and pyrexia, herbal intoxication, presence 
of diarrhoea, burns and other congenital dysfunctions commonly reported 
by the doctors in each hospital.
A structured and validated questionnaire developed by the International 
Malnutrition Taskforce and Muhimbili Hospital in Tanzania[20] was used 
for the extraction of all the data. 
Data analysis
All the data were cleaned and analysed using Stata/IC 13.0 (StataCorp., 
Texas). Subjects’ baseline clinical characteristics were summarised using 
frequency tables. The RWG and DRT were firstly inspected for normality 
using the Shapiro-Wilk and Shapiro-Francia tests, which revealed that 
they were normally distributed. The distributions of these outcomes 
across all nine baseline clinical profile variables were displayed using 
Forest Plots with means and 95% confidence intervals (CIs). Inter-group 
mean differences were assessed using one-way analysis of variance and 
independent sample t-tests, as applicable. To assess whether there were 
significant differences between the two study sites in terms of RWG and 
DRT, an independent samples t-test was used. 
Exploratory bivariate analyses were conducted using a linear regression 
model to explore the relationships between each outcome variable (RWG 
and DRT) and the nine baseline clinical characteristics as predictors. 
These relationships were further explored using multivariate regression 
analysis. The model estimates were plotted using the coefplot command 
in Stata 13.0 which displayed different levels of statistical significance for 
each predictor variable. 
To assess the relationship between the RWG and DRT, and whether 
this was influenced by HIV status or HIV clinical stage, a non-parametric 
regression analysis using a locally weighted smoothing (LOWESS) 
technique was used. This technique generated a locally weighted 
regression of the dependant variable (RWG) on the independent variable 
(DRT) and two-way locally weighted scatterplot smooths stratified 
by different levels of HIV status and HIV clinical stages. This non-
parametric method was preferred because the relationship between 
RWG and DRT did not appear to be linear during exploratory analysis. 
LOWESS was also used because it is known to generate a regression line 
which follows the data and, as such, provided a more accurate reflection 
of the relationship between the RWG and DRT.[21]
Results 
Descriptive results 
Approximately 88% of the study records for children who were discharged 
during the study period met the eligibility criteria and were included in 
this study. Subjects’ baseline clinical characteristics are presented in 
Table 1, which shows that 33.8% of SAM patients who survived and 
were discharged were HIV-positive, 15% were admitted in a critical 
condition, 28% had other comorbidities and 20% had LRTIs. A large 
proportion (86%) were younger than 25 months and 42% were admitted 
with kwashiorkor, whereas 33% were admitted with marasmus. It was 
noteworthy that 28% and 8% of patients were at stages III and IV of HIV 
infection, respectively. 
Inferential results 
The comparison of the two hospitals in terms of the distribution of the 
RWG revealed that there were no statistically significant differences 
(mean (standard deviation (SD)) 7.788 (3.121) v. 7.186 (3.421) g/kg/day; 
p=0.236). The means for DRT were also not statistically different (13.15 
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SAM = severe acute malnutrition; LRTIs = lower respiratory tract infections.
*Unless otherwise specified.
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(3.794) v. 12.011 (3.324) days; p=0.052). Pooled analyses were therefore 
carried out to determine the distribution of each of the two outcome 
indicators across various clinical characteristics at baseline, as shown in 
Figs 2 and 3. 
The mean RWG was slower with advanced HIV disease stage 
(p<0.0001), as shown in Fig. 2. Similarly, HIV-positive patients 
attained a much slower RWG compared with their HIV-negative 
counterparts (p<0.0001), as did marasmic patients compared with 
kwashiorkor and marasmic kwashiorkor, although this difference was 
not statistically significant (p=0.233). Patients who were admitted with 
other comorbidities, and those who were critically ill, attained a slower 
RWG than those who were not critically ill, but these differences were 
also not statistically significant (p=0.169 and p=0.102, respectively). The 
overall mean RWG was 7.38 g/kg/day (95% CI 6.91 - 7.84). 
All inter-group differences were not statistically significant at 95% 
significance level except for HIV status (Fig. 3). HIV-positive patients 
were hospitalised for notably longer periods (mean 18.59 days; 95% CI 
16.96 - 20.22) than their HIV-negative counterparts (mean 14.07 days; 
95% CI 13.17 - 14.97). However, there were some patterns of differences 
in other predictor variables, which are worth noting despite the lack of 
statistical significance. Marasmic SAM patients who were discharged 
remained on treatment for longer periods compared with those who 
were classified as having kwashiorkor or marasmic kwashiorkor. Patients 
without or with mild oedema (+)stayed a little longer than those with 
moderate (++) and severe oedema (+++), but there were no notable 
statistically significant differences in respect of dermatosis grade. The 
average length of stay was also longer for SAM patients at stage IV of 
HIV infection compared with other clinical stages. The mean DRTs for 
all HIV clinical stages were higher than the overall mean DRT for the 
study sample, which was 15.6 days (95% CI 14.76 - 16.44). 
Table 2 shows the bivariate relationship between patients’ baseline 
clinical profile and each of the two outcome variables in this study. 
As shown in Table 2, the DRT was significantly different among SAM 
patients depending on their SAM syndromic classification. Marasmic 
patients stayed significantly longer in the hospital than kwashiorkor and 
marasmic kwashiorkor patients (p=0.032 and p=0.001, respectively). 
HIV-positive patients, most of whom were marasmic, stayed longer 
in the hospital by four daily units compared with their HIV-negative 
counterparts (p<0.0001), whereas HIV-positive patients who were at 
stage IV stayed longer by nine daily units compared with those who 
were at stage 1 (p=0.004). Other baseline clinical characteristics were not 
significantly associated with the DRT. 
With regards to the RWG, HIV status and HIV clinical stages were the 
only clinical characteristics that were significantly associated with the 
RWG at the bivariate level. HIV-positive patients achieved a slower RWG 
by 3.3 units compared with HIV-negative patients (p<0.0001). Similarly, 
HIV-positive patients who were at stages IV, III and II attained a slower 
RWG by 3, 5 and 1 units, respectively, compared with those who were 
at stage 1; these results were statistically significant (p=0.006, p<0.0001, 
p=0.032, respectively). 
The only predictors which had a statistically significant overall effect 
on DRT were SAM syndromic classification (F (2, 343); p=0.004) and 
HIV clinical stage (F (3, 113); p=0.035). The only predictor which had 
a statistically significant overall effect on RWG was HIV clinical stage 
(F (3, 113); p<0.000). 
The multivariate model showed that HIV clinical stage was the only 
predictor of RWG and DRT at 95% level of statistical significance 
after adjusting for all other predictors in the model. The sum of all the 
predictor variables in the multivariate model explained 33% of variability 
of the RWG and 26% of variability in the DRT. The unexplained variance 
was most likely due to unmeasured confounders. 
Since none of the predictors were significantly associated with the 
RWG and the DRT in a multivariable model, except for HIV disease 
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*Inter-group dierences were statistically signicant (p<0.0001)
Fig. 2. Mean rate of weight gain (RWG) by HIV status, HIV disease stage and 
other baseline clinical characteristics: Pooled analysis based on patients who 
were discharged (2009 - 2013).
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*Inter-group dierences were statistically signicant (p<0.0001)
Fig. 3. Distribution of the duration of refeeding and treatment (DRT) by HIV 
status, HIV disease stage and other baseline clinical characteristics: Pooled 
analysis based on patients who were discharged (2009 - 2013).
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to determine the adjusted relationship between the two outcome 
variables. Therefore, a bivariate LOWESS regression was used and the 
results are presented in Figs 4 and 5. 
There were notable differences in the RWG between HIV-positive and 
HIV-negative SAM patients, as shown in Fig. 4. The locally weighted 
smooths predicted that, while HIV-negative patients who were on 
treatment for at least 10 days achieved a RWG of around 7.5 g/kg/day, 
those who were HIV-positive only attained a rate of 3.5 g/kg/day during 
the same time period (as shown by the vertical dotted lines in Fig. 4). For 
HIV-negative patients, a moderate RWG (5 - 10 g/kg/day) was achieved by 
patients who received refeeding and treatment for at least 5 days, whereas 
HIV-positive patients who attained the same RWG had to receive refeeding 
and treatment for at least 17 days. However, this analysis did not consider 
the SAM patients who had a negative RWG. There were 4 such patients 
from both facilities that were extreme outliers and distorted the position 
of the locally weighted smoothed lines significantly. It is also important to 
note that the RWG was consistently higher among HIV-negative patients 
compared with HIV-positive patients across all time intervals.
The locally weighted smoothed regression lines in Fig. 5 show that 
HIV-positive SAM patients who were at stage I achieved a faster RWG 
in a relatively shorter period of refeeding and treatment compared with 
those who were at advanced stages of HIV infection. 
Discussion 
The results of the relationship between HIV status and the RWG both 
confirm and refute evidence from past research. The current study 
showed that on average, HIV-negative SAM patients recorded a better 
RWG than their HIV-positive counterparts. The results were similar 
in both hospitals. Savadogo et al.[22] also found similar relationships 
between HIV status and the RWG; however, unlike in the present 
study, they used the median RWG as a measure of the distribution 
of the RWG by HIV status. Their results revealed that HIV-positive 
SAM patients achieved a median of 4.64 g/kg/day v. 9.04 g/kg/day for 
HIV-negative patients. Several other studies[2,5,10] have also confirmed 
this relationship. However, Fergusson et al.[11] reported similar RWGs 
between HIV-positive and -negative SAM patients (mean 8.0 v. 8.9 
g/kg/day, respectively). In the present study, the poorer nutritional 
recovery observed among HIV-positive SAM patients may, in part, 
be a result of metabolic changes associated with HIV infection, which 
impact on the nutritional status of the child. These changes include, 
Table 2. Relationship between baseline clinical characteristics of SAM cases and two outcomes (DRT (days) and RWG (g/kg/day)): 
Bivariate regression analysis
Outcomes 
DRT (days) RWG (g/kg/day)
Factors β 95% CI p-value β 95% CI p-value
SAM syndromic classification
Marasmus Ref Ref
Kwashiorkor –2.126 –4.065 - –0.186 0.032 0.396 –0.681 - 1.473 0.470
Marasmic kwashiorkor –3.907 –6.051 - –1.564 0.001 0.559 –0.684 - 1.803 0.377
Oedema grade
None Ref Ref
Mild 0.241 –3.383 - 3.866 0.896 0.942 –1.039 - 2.924 0.350
Moderate –2.404 –4.630 - –0.177 0.134 0.974 –0.245 - 2.194 0.117
Severe –1.713 –3.820 - 0.394 0.111 0.647 –0.512 - 1.807 0.273
Dermatosis grade
None Ref Ref
Mild 0.486 –1.834 - 2.806 0.680 0.813 –0.449 - 2.075 0.206
Moderate –0.585 –2.681 - 1.519 0.583 -0.343 –1.484 - 0.797 0.554
Severe –0.864 –3.945 - 2.2162 0.581 0.161 –1.546 - 1.870 0.853
Presence of LRTIs 
No Ref Ref
Yes 1.255 –0.847 - 3.358 0.241 0.065 –1.089 - 1.221 0.911
Other comorbidities
No Ref Ref
Yes 0.931 –0.934 - 2.795 0.327 –0.514 –1.53 - 0.506 0.322
Critically ill on admission 
No Ref Ref
Yes –0.996 –3.344 - 1.352 0.405 –0.23 –1.517 - 1.043 0.716
HIV status 
Negative Ref Ref
Positive 4.51 2.795 - 6.243 <0.001 –3.314 –4.225 - –2.403 <0.001
HIV clinical stage 
I Ref Ref
II 1.125 –2.932 - 5.182 0.584 –1.773 –3.388 - –0.159 0.032
III 1.973 –2.338 - 6.285 0.366 –5.343 –7.059 - –3.627 <0.001
IV 9.680 3.123 - 16.238 0.004 –3.67 –6.282 - –1.063 0.006
SAM = severe acute malnutrition; DRT = duration of refeeding and treatment (days); RWG = rate of weight gain (g/kg/day); CI = confidence interval;  
Ref = reference group; LRTIs = lower respiratory tract infections.
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for example, hyper-metabolism of energy stores, nutrient losses and 
malabsorption as a result of inflammation of the gastrointestinal 
tract, reduced bioavailability of certain nutrients, and altered nutrient 
utilisation.[23] Poor appetite, which results in inadequate nutrient 
intake, has also been documented.[12] HIV-positive patients tend to 
present with severe oral and oesophageal candidiasis which undermine 
stherapeutic feeding efforts.[24] This finding begs a question as to 
whether a much more aggressive therapeutic feeding approach and 
treatment modality for HIV-positive SAM patients with associated 
comorbidities may be required to counteract these pathophysiological 
and metabolic challenges that HIV infection presents among SAM 
patients. The finding related to the relationship between DRT and 
HIV status agrees with results from a study by Madec et al.,[25] who 
showed that the duration of refeeding was much longer among HIV-
positive patients (mean 22 days) than in HIV-negative patients (mean 
12 days). However, these estimates were larger than those found in our 
study which recorded means of 14.07 and 18.59 days for HIV-negative 
and HIV-positive SAM patients, respectively. These differences may 
be related to the concomitant differences in discharge criteria set 
out in the study. The study by Madec et al.[25] seems to imply that 
the minimum number of days required to achieve good nutritional 
recovery is roughly 22 for HIV-positive SAM patients and 12 for HIV-
negative patients. However, neither the present nor Madec’s study 
were able to provide precise quantifiable targets, such as time taken 
to achieve weight-for-height z-scores, which are oedema-free. In the 
present study, weight-for-height z-scores were not used as the medical 
records did not always have data on patient length and height. 
Perhaps the most important contribution to the literature from our 
study is the estimation of the relationship between HIV disease stage and 
the RWG. The study showed that the mean RWG became smaller with 
advanced HIV disease stage. The relationship between the RWG and 
HIV disease stage can be explained in light of the randomised controlled 
trial which demonstrated that half the children hospitalised for 
SAM developed oedema after starting antiretroviral therapy (ART).[26] 
Oedema may be associated with a slower RWG as children with oedema 
have to lose weight during the rehabilitation phase before they gain 
non-oedema-associated weight. Another possible explanation for 
this observation is that oedematous children are often more ill and 
unable to adequately metabolise nutrients. The evidence around this 
physiological process is still poorly understood. 
Another key finding from this study was the estimation of the relationship 
between the RWG and DRT and how these variables can be influenced by 
HIV status and disease stage. The non-linear polynomial regression and 
scatter plot smooths estimated that the trajectory to better RWG was faster 
and consistently higher among HIV-negative SAM patients compared with 
their HIV-negative counterparts. To our knowledge, this finding has not 
been documented elsewhere in the literature and may need to be verified 
in future studies, within a variety of contexts. Nevertheless, against the 
backdrop of this study, where resources for prolonged management of SAM 
patients may be relatively fewer, the fact that HIV-positive SAM patients 
took longer to attain the same RWG as their HIV-negative counterparts 
may have some practical implications to consider. To optimise outcomes in 
respect of nutritional recovery, it may be important to prioritise resources 
for HIV-positive SAM patients, particularly the availability of hospital beds 
and therapeutic feeds, in addition to medication stock for SAM-related 
comorbidities. 
Study limitations 
The measurement of quality of care for SAM patients and its 
relationship with the outcome variables (RWG and DRT) was beyond 
the scope of this study and is encouraged in future research. However, 
it was encouraging to learn that there were no statistically significant 
differences between the two hospitals in terms of the distribution 
of the two outcomes and how they were related to the predictor 
variables. Furthermore, only 88% percent of the available medication 
records for children who were discharged during the entire study 
period met all the eligibility criteria for record review. It is not known 
what the remaining 12% would have contributed to the direction and 
strengths of the relationships presented in this study. There is also 
limited generalisability of the results presented here, as the study was 
conducted in purposefully selected facilities where the implementation 
of the WHO treatment modality for SAM was presumed optimal. 
Lastly, but not least, patient records did not always have an indication 
of whether the study subjects were already on ART at admission, and 
for how long they had been on treatment. This information could not 
be verified since the study involved a retrospective record review. This 
information would have constituted important variables to assess as 
potential confounders or predictors of the RWG and DRT. Given the 
design limitation of this study, the recommendations made in this 
article in relation to the WHO protocol should not be considered as 
definitive but rather suggestive. 
Conclusions 
The findings from this study suggest that nutritional recovery is, in part, 
a function of HIV status, HIV disease stage and the duration of refeeding. 
Our findings raise some important research topics to be explored in 
future research studies, including, for example, the determination of 
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Fig. 4. Relationship between rate of weight gain (RWG) and duration of refeeding 
and treatment (DRT) by HIV status: Two-way scatter plot with locally weighted 
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Fig. 5. Two-way scatter plots with locally weighted smoothed regression curves 
and linear plot overlays showing the relationship between the rate of weight gain 
(RWG) and duration of r-enutrition and treatment (DRT) by HIV clinical stage.
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their HIV status. Such studies can also explore the optimal choice of 
therapeutic feeds during the transition phase for HIV-positive SAM 
patients and how long it takes SAM patients, with or without HIV 
infection, to achieve specific targets for nutritional recovery in terms of 
the weight-for-height z-scores. 
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